Strategic report Governance IFRS financial statements Other information Notes to the consolidated financial statements Continued 34 Direct capital instrument and tier 1 notes 2017 2016 Notional amount m m 5.9021% 500 million direct capital instrument Issued November 2004 500 500 8.25% $650 million fixed rate tier 1 notes Issued May 2012 392 6.875% 210 million STICS Issued November 2003 231 231 Total 731 1,123 The direct capital instrument the DCI was issued on 25 November 2004.
The DCI has no fixed redemption date but the Company may, at its sole option, redeem all but not part of the principal amount on 27 July 2020, at which date the interest rate changes to a variable rate, or on any respective coupon payment date thereafter.
The variable rate will be the six month sterling deposit rate plus margin.
The $650 million fixed rate tier 1 notes the FxdRNs were issued on 3 May 2012.
On 28 September 2017 notification was given that the Group would redeem the FxdRNs at first call date on 3 November 2017.
At the notification date the instrument was reclassified as a financial liability of 484 million, representing its fair value on translation into sterling at that date.
The resulting foreign exchange loss of 92 million has been charged to retained earnings.
The FxdRNs were redeemed in full on 3 November 2017 at a cost of 488 million, including an additional 4 million of exchange losses subsequent to the reclassification which are included within other expenses within the income statement.
The Step-up Tier one Insurance Capital Securities STICS were issued on 21 November 2003 by Friends Life Holdings plc, substituted as issuer by Aviva plc on 1 October 2015.
The STICS are irrevocably guaranteed on a subordinated basis by Aviva Life & Pensions Limited.
Prior to the Part VII transfer of the Friends Life business into UK Life on 1 October 2017 the guarantor for the STICS was Friends Life Limited.
The STICS have no fixed redemption date but the Company may, at its sole option, redeem the instrument in whole or in part on 21 November 2019, or on the coupon payment date falling on successive fifth anniversaries from this date.
For each coupon period beginning 21 November 2019, the STICS will bear interest reset every five years at the rate per annum which is the aggregate of 2.97% and the Gross Redemption Yield of the Benchmark Gilt.
The Company has the option to defer coupon payments on the DCI and the STICS on any relevant payment date.
In relation to the DCI, deferred coupons shall only be satisfied should the Company exercise its sole option to redeem the instruments.
In relation to the STICS, deferred coupons may be satisfied at any time, at the sole option of the Company.
The Company is required to satisfy deferred coupons upon the earliest of the following: Resumption of payment of coupons on the STICS: or Redemption: or The commencement of winding up of the issuer.
No interest will accrue on any deferred coupon on the DCI.
Interest will accrue on deferred coupons on the STICS at the then current rate of interest on the STICS.
Deferred coupons on the DCI and the STICS will be satisfied by the issue and sale of ordinary shares in the Company at their prevailing market value, to a sum as near as practicable to and at least equal to the relevant deferred coupons.
In the event of any coupon deferral, the Company will not declare or pay any dividend on its ordinary or preference share capital.
These instruments have been treated as equity.
Please refer to accounting policy AE.
At the end of 2017 the fair value of the DCI and the STICS was 778 million 2016: 736 million.
Aviva plc Annual report and accounts 2017 164
